Ken Moseley

Vice President, BELLICUM PHARMACEUTICALS, INC.

Companies

Marker Therapeutics, Inc.General counsel Dec 28, 2018 to Dec 28, 2018¹
BELLICUM PHARMACEUTICALS, INCGeneral counsel Jul 6, 2015 to Jan 5, 2018²
BELLICUM PHARMACEUTICALS, INCVice President Dec 17, 2014 to Feb 26, 2015³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMarker Therapeutics, Inc., General counsel
2
SEC EDGARBELLICUM PHARMACEUTICALS, INC, General counsel
3
SEC EDGARBELLICUM PHARMACEUTICALS, INC, Vice President